v3.25.3
Organization, Basis of Presentation and Significant Accounting Policies (Details)
1 Months Ended 3 Months Ended 9 Months Ended
May 31, 2024
USD ($)
Sep. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Sep. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
transaction
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Accounting Policies [Abstract]                    
Working Capital   $ 31,556,897           $ 31,556,897    
Accumulated deficit   172,432,523           172,432,523   $ 130,949,672
Cash, cash equivalents, and short-term investments   35,312,308           35,312,308    
Operating loss   13,264,534     $ 4,968,796     43,268,021 $ 19,526,617  
Net loss for nine months ended   12,754,660 $ 17,624,872 $ 11,103,319 $ 3,898,297 $ 7,902,816 $ 5,019,531 41,482,851 $ 16,820,644  
Number of private placement equity transactions | transaction             2      
Proceeds from issuance of private placement             $ 83,556,563      
Sale of stock, shares authorized in equity distribution agreement, value $ 100,000,000                  
Estimated loss contingency   $ 2,054,357           $ 2,054,357